Moreover, the inhibitor treatment decreased the expression of genes that encode adhesion molecules, such as MCAM, which encode the Cell Surface Glycoprotein MUC18; and growth factor, as a member of Fibroblast Growth Factor encoded by FGF1 gene, both molecules key to the cell adhesion and tumor progression. The gene discussed is FGF1; the disease is neoplasm.